Fragile X mental retardation protein (FMRP) belongs to a small family of RNA-binding proteins. Its absence or inactivity is responsible for fragile X syndrome, the most common cause of inherited mental retardation. Despite its ubiquitous expression, FMRP function and expression remain almost understudied in non-neuronal tissues, though previous studies on germline development during oogenesis may suggest a special function of this protein also in ovarian tissue. In addition, the well-documented association of FMR1 premutation state with fragile X-related premature ovarian insufficiency adds interest to the role of FMRP in ovarian physiology. The aim of the present work was to investigate the expression of Fmr1 mRNA and its protein, FMRP, at different stages of rat follicular development. By immunohistochemical studies we demonstrated FMRP expression in granulosa, theca and germ cells in all stages of follicular development. In addition, changes in Fmr1 expression, both at the protein and mRNA levels, were observed. FMRP levels increased upon follicular development while preantral and early antral follicles presented similar levels of Fmr1 transcripts with decreased expression in preovulatory follicles. These observations suggest that Fmr1 expression in the ovary is regulated at different and perhaps independent levels. In addition, our results show expression of at least four different isoforms of FMRP during all stages of follicular growth with expression patterns that differ from those observed in brain and testis. Our study shows a regulated expression of Fmr1, both at mRNA and protein levels, during rat follicular development.
Introduction
Fragile X mental retardation protein (FMRP) belongs to a small family of RNA-binding proteins. It contains several motifs involved in binding to RNA: two heterogeneous nuclear ribonucleoprotein (hnRNP)-K-homology (KH) domains and an arginine-glycine-glycine (RGG box). The protein is encoded by the FMR1 gene, which is composed of 17 exons, spans about 40 kb and encodes an mRNA of 3.9 kb that can be alternatively spliced into a number of different isoforms , Verkerk et al. 1993 . In addition, FMRP has been shown to undergo two post-translational modifications: phosphorylation and arginine methylation , Stetler et al. 2006 . It has been suggested that phosphorylation might modulate FMRP properties such as association with actively translating polyribosomes and with Dicer (Ceman et al. 2003 , Cheever & Ceman 2009 ) while methylation affects both its protein-protein and protein-RNA interactions (Denman 2002 , Dolzhanskaya et al. 2006 , Stetler et al. 2006 , Blackwell et al. 2010 , Blackwell & Ceman 2012 . The presence of a nuclear localization signal and a nuclear export signal suggests shuttling between the nucleus and the cytoplasm (Eberhart et al. 1996) . Nevertheless, FMRP is mostly in the cytoplasm (Devys et al. 1993) , where it is found associated with polyribosomes as part of large messenger-ribounucleoprotein (mRNP) particles. The FMRP-mRNP complex contains several other proteins including fragile X mental retardation syndrome-related protein 1; (FXR1P) and FXR2 (FXR2P) (Tamanini et al. 1996 , Ceman et al. 1999 , 2000 . Notably, the absence or inactivity of FMRP is responsible for fragile X syndrome (FXS), the most common cause of inherited mental retardation (for review, see O'Donnell & Warren (2002) ). Strong evidence supports a role of FMRP in the regulation of specific target mRNA translation; moreover, dysregulation of protein synthesis at the neuronal synapse has been proposed as one of the mechanisms underlying FXS , Laggerbauer et al. 2001 , Mazroui et al. 2002 . Results obtained from several studies suggest that the microRNA pathway may be one of the mechanisms by which FMRP could modulate mRNA translation. Studies in Drosophila have demonstrated an interaction of Drosophila fmr1 (dFmr1) with artgonaute 2 (AGO2) and Dicer, both components of the iRNA machinery, which suggests that dFmr1 is part of the RNA-induced silencing complex (RISC) in Drosophila (Caudy et al. 2002 . Similarly, mammalian FMRP has been shown to interact in vivo with microRNA (miRNA) and with the components of the miRNA pathway (Jin et al. 2004) . Notably, though FMRP expression is ubiquitous, it is most abundantly expressed in neurons and testis (Devys et al. 1993 , Tamanini et al. 1997 , Bakker et al. 2000 , both tissues affected in fragile X patients. In mice, an enhanced expression of Fmr1 during germ cell proliferation was described, suggesting a special function for Fmr1 in germ cells of both sexes (Bachner et al. 1993) . Interestingly, a more recent study using Drosophila dFmr1 mutants demonstrated that dFmr1 is required for germline stem cell maintenance and repression of differentiation in the ovary, probably via the miRNA pathway (Yang et al. 2007) . Another Drosophila FXS model showed that FMRP controls germline proliferation during oogenesis by regulating the expression of casitas B-lineage lymphoma proto-oncogene (cbl) in the developing ovary (Epstein et al. 2009) .
Notably, the UTR of the FMR1 gene presents a CGG repeat that is unstable and therefore variable in the population. Based on the size of the expansion, individuals are classified as having normal (5-54 trinucleotide repeats), premutated (55-200 repeats), or fully mutated (O200 repeats) alleles (Fu et al. 1991 , Oberle et al. 1991 , Rousseau et al. 1995 . Full mutated alleles usually result in hypermethylation of the CpG site in the promoter region of the FMR1 gene (Bell et al. 1991) , which leads to gene silencing; the subsequent absence of the protein is therefore responsible for FXS. Conversely, carriers of the premutation have increased levels of FMR1 mRNA (twofold to eightfold in lymphocytes) due to increased transcription rate of the gene (Tassone et al. 2000 (Tassone et al. , 2007 . Premutation state is associated with two clinical disorders: fragile X-associated tremor/ataxia syndrome (FXTAS), a lateonset neurodegenerative disorder, and fragile X-related premature ovarian insufficiency (FXPOI). The increased levels of CGG-containing FMR1 mRNA along with the presence of ubiquitin-positive intranuclear inclusions observed in both neurons and astrocytes of FXTAS patients and in animal models led to the suggestion that a toxic RNA gain of function mechanism may underlie FXTAS development. Indeed, inclusions were also found in tissues other than the CNS in subjects with FXTAS (e.g. testicles and peripheral nerve ganglia) (for review, see Garcia-Arocena & Hagerman (2010) ). FXPOI is defined as premutation carriers having menopause before the age of 40 years, ovarian dysfunction, and decreased fertility (Allingham-Hawkins et al. 1999) . Based on several studies, w20% of premutation carriers have FXPOI compared to only 1% in the general population. Conversely, among women with idiopathic sporadic premature ovarian failure, w2-14% are estimated to carry a FMR1 premutation (Sherman 2000) .
Despite its ubiquitous expression FMRP function and expression remain almost understudied in non-neuronal tissues. Though within the periphery FMRP is most abundantly expressed in the testis, previous studies on germline development during oogenesis may suggest a special function of this protein in ovarian tissue as well. Indeed, the well-documented association of premutation state with FXPOI adds interest to the question of the role of FMRP in ovarian physiology. Considering that to date the function of this protein in the ovary has been barely explored, a detailed description of the expression of FMR1 during ovarian development seems necessary. Thus, in the present work we aimed to investigate the expression of Fmr1 mRNA and its protein, FMRP, at different stages of rat follicular development.
Results

Follicular granulosa and theca cells express FMRP at all stages of folliculogenesis
Results of immunohistochemical staining for FMRP in ovarian sections from untreated, diethylstilbestrol (DES)-or PMSG-treated prepubertal rats is shown in Fig. 1 . Follicles at different developmental stages can be distinguished by their morphological features, such as size and number of granulosa cell (GC) layers. Preantral follicles (PAF) present an oocyte surrounded by two to four layers of GC and are 120-200 mm in diameter, whereas a small antral cavity and a thin theca layer can be distinguished in early antral follicles (EAF), which are about 300-400 mm in diameter. The oocyte becomes acentrically displaced by the developing antrum in preovulatory follicles (PF), which present a well-defined and thick granulosa layer and are more than 450 mm in diameter (Hirshfield & Midgley 1978) .
In sections from untreated rats, FMRP staining was seen in GC and theca cells (TC) as well as in the stroma of PAF (Fig. 1A) , but no differences in intensity could be distinguished between different cell types. No staining was observed in the ovarian cortex while the oocyte cytoplasm in primordial follicles showed intense labeling (Fig. 1D) .
In ovaries from DES-and PMSG-treated rats, intense FMRP immunostaining was observed in GC and TC as well as in the few stromal cells that can be found at these late stages of development ( Fig. 1B and C) .
In ovaries at all three stages of folliculogenesis, no positive staining was detected in the stromal cells surrounding the follicles; it is worth noting that these stromal cells might belong to the vascular network (Fig. 1A , B and C). FMRP staining in atretic follicles was weaker than in healthy ones (Fig. 1E ). The oocyte showed positive immunostaining in all follicular stages studied. The FMRP expression pattern was similar among follicles of the same type from prepubertal, DES-and PMSG-treated rats. Furthermore, when analyzing untreated 60-day-old postpubertal cycling rats we observed a similar expression pattern of FMRP at each follicular stage between hormonally untreated and treated immature female rats. Expression of FMRP was also detected in luteal cells of these adult rats (Fig. 1I ). In addition, FMRP labeling in the nucleus was detected only in a small fraction of the cells (Fig. 1J , and data not shown).
FMRP expression increases as the follicle grows
FMRP expression in isolated follicles and in whole ovaries was analyzed by western blot (WB) in all three experimental groups (untreated, DES-or PMSG-treated prepubertal rats). When isolated follicles were analyzed FMRP expression was low in PAF and increased progressively in EAF and PF ( Fig. 2A ). Though the differences did not reach statistical significance, a clear tendency to a higher expression in PF was observed. Four isoforms of the protein could be detected; all of them proportionally increased their expression as folliculogenesis progressed. Considering that most expected isoforms have similar molecular weights and might therefore be hard to discriminate in a polyacrylamide gel, the presence of additional variants cannot be ruled out.
The differences in FMRP expression observed during folliculogenesis persisted when analysis was performed relative to expression levels of S6, another ribosomal protein ( Fig. 2A ), ruling out a generalized increment of ribosomal protein synthesis during follicular development. In addition when whole ovary proteins were analyzed the same FMRP expression pattern was observed (data not shown).
Given the well-documented high expression of FMRP in testis and brain (Devys et al. 1993 , Tamanini et al. 1997 , Bakker et al. 2000 , and the lack of FMRP expression in skeletal muscle (Devys et al. 1993 , Khandjian et al. 1998 , Bakker et al. 2000 , these tissues were used as positive and negative controls respectively ( Fig. 2B and C) . As shown in Fig. 2B , a high expression of the protein was observed in the testis. Four isoforms were also expressed in this tissue but their relative expression differed from that observed in the ovary. While no significant differences were observed in the expression levels of the diverse isoforms in the ovary, the highmolecular-weight isoforms were more abundant in both testis and brain (Fig. 2B ).
Fmr1 mRNA expression
Following the analysis of protein expression, we aimed to determine whether protein synthesis correlated with gene expression rate at mRNA level. Fmr1-specific primers amplify a region of mRNA in which no splicing events occur and thus the results obtained correspond to all possible transcribed isoforms. As shown, the Fmr1 mRNA expression pattern was opposite to the one obtained for protein expression: the lowest values of mRNA were observed in PMSG-treated rats, both in isolated PF (Fig. 3A ) and in the whole ovary (Fig. 3B ), and these differences were statistically significant (P!0.05). When other tissues were analyzed as controls, a clear tendency toward a higher expression was observed in the testis, while similar levels were detected in muscle, brain, and ovarian follicles (Fig. 3C ).
Discussion
The FMR1 gene is transcribed and translated in many tissues including the ovary. Nevertheless, and despite the well-documented association of FMR1 premutation CGG trinucleotide repeats (range 55-200) and FXPOI the physiological expression and function of the gene in follicular development remain barely explored. So far, the function of FMRP in the ovary has been studied in Drosophila models, where it may be involved in germ cell and oocyte specification (Costa et al. 2005 , Megosh et al. 2006 as well as in the maintenance of germline stem cells, probably regulating the translation of specific mRNAs via the miRNA pathway (Yang et al. 2007) . A role in the control of germline proliferation was also demonstrated (Epstein et al. 2009 ), thus suggesting an early stage-specific function of Fmr1 in germ cells.
In this study we demonstrated changes in Fmr1 expression, both at the protein and mRNA levels, and described FMRP cellular localization at different stages of follicular development in the rat ovary. We used untreated, DES-and PMSG-treated prepubertal rats in order to include the most representative stages of ovarian follicular development. This rat model is suitable for our purpose as in the immature ovary (mainly composed of PAF/EAF), DES and PMSG hormonal treatment triggers the maturation of a large cohort of follicles that synchronously progress through small-to mediumsized antral and preovulatory stages respectively (Rani et al. 1983 , Karakji & Tsang 1995 . The DES and PMSG treatments are widely used as models to study follicular dynamics under physiological conditions (Billig et al. 1993 , Chun et al. 1996 , Li et al. 1998 .
By immnuhistochemical studies, we detected FMRP expression at all stages of follicular development, including the germ cell. GC and TC from untreated, DES-and PMSG-treated rats showed positive FMRP immunostaining. It is noteworthy that the changes observed in the different follicular stages induced by the hormonal treatments used are a reflection of data obtained in ovaries from adult cycling rats, suggesting that these observations have a physiological correlate and are not merely the result of the hormonal treatments. In adult rats FMRP immunostaining was also observed in luteal cell indicating a possible role of the protein in corpus luteum function as well. Similarly, FMRP expression was described in mouse female fetal primordial cells and also in follicular cells in the adult (Bakker et al. 2000) . Recent works by Hoffman et al. (2012) and Lu et al. (2012) described expression of FMRP in murine granulosa and luteal cells as well as in the oocyte. In addition, FMRP expression in ovaries from women of different ages has also been described, mainly in the oocyte and GCs (Schuettler et al. 2011 , Willemsen et al. 2011 . In accordance with the nuclear localization and export signals present in the protein (Eberhart et al. 1996) , and consistently with the expression of the protein mostly in the cytoplasm (Devys et al. 1993) , we detected only a small fraction of cells showing positive FMRP immunostaining in the nucleus.
As a result of the alternative splicing of the Fmr1 mRNA numerous isoforms of the protein can be synthesized, an argument in favor of particular cellular roles for the individual isoforms (Ashley et al. 1993 , Sittler et al. 1996 , Denman & Sung 2002 . In addition, phosphorylation and methylation have been described as post-translational modification of FMRP , Stetler et al. 2006 . Our results showed expression of at least four different isoforms in the rat ovary during all stages of follicular growth. The differences observed in isoform expression patterns in the ovary compared to brain and testis might suggest a specific function for some of the isoforms in this tissue. Strikingly, different levels of all FMRP isoforms are detected by WB during follicular development; a lower protein level was observed in PAF, while expression increased in EAF and PF, and these differences were even more evident during preantral to early antral transition. The preantral to early antral transition is the one most susceptible to atresia (Hirshfield 1991) ; important changes in protein translation may thus occur during this period to overcome atresia and continue with folliculogenesis. Considering that FMRP is a major cellular translational repressor protein that binds to multiple transcripts thereafter controlling their translation rate (Laggerbauer et al. 2001 , Schaeffer et al. 2001 , Schuettler et al. 2011 , low amounts of the protein during the preantral stage could allow a more permissive translation of target mRNAs, while a progressive repressing state would be expected in developing follicles. As FMRP has been shown to interact with miRNA and the components of the miRNA pathway (Caudy et al. 2002 , Jin et al. 2004 , and considering that miRNAs have an important role in post-transcriptional gene regulation in the ovary and in the female reproductive tract in general (Fiedler et al. 2008 , Carletti & Christenson 2009 , Christenson 2010 , it seems natural to assign to the protein a crucial role in the adequate functioning of the gonad. Defects in regulatory control can lead to ovarian failure due to disruption of folliculogenesis, block of ovulation and corpus luteum insufficiency, among others (Carletti & Christenson 2009 ). Moreover, ovarian follicle development largely depends on the proliferation of GCs. GC proliferation commences from primary follicle formation, and the follicle growth is characterized by increasing layers of GCs (Zhang et al. 2011) . Considering that the GC is the follicular cell type that undergoes the greatest changes in size and number during the development of the follicle, our results could also be a measure of the contribution of the expression of FMRP in this cell type to the regulation of ovarian physiology. Contrary to results obtained at the protein level, PAF and EAF presented similar levels of Fmr1 transcripts, while decreased expression was observed in PF, suggesting that Fmr1 expression in the ovary is regulated at different and perhaps independent levels. Supporting this idea, even though no FMRP could be detected in muscle, mRNA was expressed in this tissue. Similarly, increased FMRP levels found in the barrel cortex after unilateral whisker stimulation were not accompanied by changes in Fmr1 mRNA (Todd et al. 2003 ). An increment in either mRNA stability or protein translation rate in the late stages of folliculogenesis might account for the discrepancies found between RNA and protein levels. In line with this contention, the fact that FMRP has been shown to bind to a significant percentage of brain mRNAs, including Fmr1 mRNA itself , Schaeffer et al. 2001 , Didiot et al. 2008 , and that FMRP has been implicated as a direct modulator of mRNA turnover, has led to suggestion of a possible role for FMRP in mRNA stability (De Rubeis & Bagni 2010 . However, a direct effect of FMRP on its own mRNA stability remains to be established. Ultimately, our in vivo data could indicate a putative regulation of Fmr1 mRNA levels of enhanced FMRP expression in advanced follicular development.
Several mouse models carrying human FMR1 repeats in the premutation range have been developed. Histological analysis in a knock-in model with 130 CGG repeats revealed ovarian abnormalities (Hoffman et al. 2012) . In addition, the characterization of a transgenic mouse carrying a premutation of 90 CGG repeats showed that premutated RNA impaired female fertility, reduced the number of growing follicles and altered selective serum hormone levels, thus resembling FXPOI in humans (Lu et al. 2012) . Given the advanced technologies in transgenic and knock-in models in rat, and taking into account the data presented in our work, it would be an interesting challenge to develop a rat model of FXPOI to further contribute to the better understanding of the influence of FMR1 CGG repeats in ovarian pathophysiology.
Conclusions
This study shows for the first time, to our knowledge the regulated expression of Fmr1, both at the mRNA and protein levels, during rat follicular development. Further studies may be necessary to confirm whether this protein is involved in the functional changes that occur during folliculogenesis.
Materials and Methods
Animal preparation
All procedures in this study were approved by the Ethics Committee of the Institute of Biology and Experimental Medicine (IByME-CONICET) and are in accordance with National Institute of Health standards, as described in the guide for Care and Use of Laboratory Animals.
Prepubertal female Sprague-Dawley rats (18-to 23-days old) and 60-days -old rats were allowed access to food and water ad libitum and kept at room temperature (21-23 8C) on a 12 h light:12 h darkness cycle.
To obtain ovaries enriched with follicles at different developmental stages, rats were injected s.c. either with DES (1 mg/rat, Sigma Chemical Co.) dissolved in corn oil, daily, for 3 days, to stimulate the development of EAF or with a single injection of equine chrorionic gonadotropin (PMSG, 25 IU/rat, Novormon, Syntex S.A. Buenos Aires, Argentina) 48 h before the experiment, to stimulate the development of PF (Li et al. 1998) . Ovaries enriched with PAF were obtained from untreated prepubertal rats. Rats were killed by CO 2 asphyxiation and ovaries were removed and cleaned of adhering tissue.
Follicle isolation
For isolation of PAF ovaries obtained from six to twelve 18-day-old rats were minced using 26G1/2 syringe needles according to the method of Flaws et al. (1994) . Briefly, minced tissue was dissociated by incubation in 2.5 ml DMEM-F12 (Gibco Laboratories) with HEPES (Sigma Chemical Co.) containing collagenase (4800 units; 217 U/mg; Gibco), DNase (1910 units, 10 mg/ml, D4527, Sigma) , and 1% BSA (A7888, Sigma), in a water shaking bath at 37 8C for 20 min. The dissociated tissue was then washed three times in DMEM-F12 HEPES and passed through a nylon filter with 210 mm pores (Small Parts CMN-210, Miramar, FL, USA). All excluded structures (follicles O210 mm in diameter and corpora lutea) were discarded and follicles smaller than 210 mm were considered PAF.
Ovaries from DES-and PMSG-treated rats were used to obtain EAF (300-400 mm) and PF (O450 mm) follicles respectively. In both cases, individual ovarian follicles were dissected from the ovary under a stereoscopic microscope using fine needles, as described previously (Parborell et al. 2002 , Abramovich et al. 2009 ).
Immunohistochemistry
Sections of formalin-fixed paraffin-embedded tissue were deparaffinized in xylene and rehydrated in graded ethanol washes. Endogenous peroxidase activity was blocked with 3% hydrogen peroxide in PBS (pH 7.2) for 20 min followed by successive PBS washes. For antigenic exposure, slides were heated in a microwave oven in citric acid buffer 0.01 M (pHZ6) for 10 min at 600 W. Nonspecific binding was blocked with 2% BSA for 20 min. Sections were incubated overnight at 4 8C in a humidified chamber with or without (negative control) anti-FMRP antibody in PBS (1/400, clone 1C3, Millipore, Billerica, MA, USA). Slides were washed in PBS and FMRP detected with a biotin-conjugated goat anti-mouse IgG (1/400, 30 min, RT, Vector Laboratories, Burlingame, CA, USA) followed by avidin-biotinylated HRP complex (Vectastain ABC system; Vector Laboratories) for 30 min. Immunoreactivity was visualized with diaminobenzidine staining. The reaction was stopped with distilled water, stained with hematoxylin, dehydrated in graded alcohols and mounted. For a better visualization of the putative expression in the nucleus, no hematoxylin counterstain was used. The appearance of a brown reaction product was observed by light microscope.
Western blot
For WB analyses, either ovarian tissue from three or four rats or isolated follicles from 12 to 24 ovaries per treatment were pooled and resuspended in 600 ml lysis buffer (20 mM Tris-HCl, pH 8, 137 mM NaCl, 1% NP-40 and 10% glycerol) supplemented with protease inhibitors (104 mM 4-(2-Aminoethyl) benzenesulfonyl fluoride hydrochloride (AEBSF) 80 mM aprotinin, 4 mM bestatin, 1.4 mM E-64, 2 mM leupeptin, and 1.5 mM pepstatin A, Sigma) and homogenized with an Ultra-Turrax (IKA Werk, Breisgau, Germany) homogenizer. The results obtained from each pool of ovarian tissue or follicles were considered a single datum.
Assays were performed according to the methodology described by Feng et al. (1997) , with slight modifications. Briefly, samples were centrifuged at 4 8C for 15 min at 16 000 g, and the resulting supernatant centrifuged at 4 8C for 1 h at 150 000 g to obtain a pellet enriched in ribosomes. The supernatant was discarded and the pellet was resuspended in urea buffer (1% Triton-X, 100 mM Tris-HCl, pH 6.8, and 6 M urea). Protein concentration was measured by the Bradford assay.
As control tissues, testis, brain and muscle were obtained, homogenized, and centrifuged as described earlier. Lysis buffer for muscle homogenization contained 50 mM Tris-HCl (pH 7.5), 1 mM EDTA, 1 mM EGTA, 150 mM NaCl, 10% glycerol, 1% NP-40, 0.1% SDS, and 1 mM MgCl 2 . Brain buffer contained 40 mM Tris-HCl, 120 mM NaCl, 2 mM Na 3 VO 4 , 1% Triton-X 100, and 1 mM PMSF. For testis homogenization, the same buffer as for follicles and ovaries was used. A total of 12 mg protein was loaded on 7.5% SDS-PAGE was performed at 25 mA for 1.5 h. Proteins were transferred into a nitrocellulose membrane for 1 h. FMRP and b-actin blots were blocked at 4 8C overnight in PBS containing low-fat powdered milk (5%) and Tween 20 (0.2%) followed by incubation with mouse monoclonal anti-FMRP 1C3 (1/4000) or mouse anti-b-actin (1/10 000 ab-6276 Abcam; Cambridge Science Park, UK) for 2 h at room temperature in 0.2% Tween 20 in PBS. S6 blots were blocked in the same blocking solution as described earlier for 1 h at room temperature and incubated with anti-mouse monoclonal S6 antibody (1/1000, 54D2, Cell Signaling, Danvers, MA, USA) in blocking solution overnight at 4 8C. Anti-mouse antibody conjugated to HRP was used as a secondary antibody, and the signal was detected by chemiluminescence and autoradiography. For quantification screening was performed with X-ray film using different times of exposure to optimize the signal. Protein levels were compared and analyzed by densitometry using the Image J software (NIH). The density of each band was normalized to the density of the b-actin band used as an internal control. Three independent protein extracts were obtained for each experimental group.
Real-time RT-PCR
To quantify Fmr1 mRNA levels in DES-or PMSG-treated rats, whole ovaries or isolated follicles from four rats were used. Each rat extract was assayed individually. For the prepubertal group, four rats were used when the whole ovary was assayed, while three groups of six rats each were used for isolated follicles.
Total RNA was extracted using Trizol reagent (MRC, Cincinatti OH, USA) according to manufacturer's instructions. Purified RNA was stored at K70 8C until cDNA synthesis. Complementary DNA templates for PCR amplification were synthesized from 1 mg total RNA using random primers and M-MLV Reverse Transcriptase (Promega) in a total volume of 25 ml. Before real-time PCR studies, cDNA synthesis was verified by regular PCR using primers for Fmr1 and running at 94 8C for 1.5 min, following with 35 cycles at 94 8C for 40 s, 56 8C for 30 s, 72 8C for 1.5 min, and a final extension at 72 8C for 10 min. Results were monitored by agarose gel electrophoresis.
Real-time PCR was performed using SYBR GREEN PCR Master Mix (Applied Biosystems) and the forward 5 0 -agatcaagctggaggtgcca-3 0 and reverse 5 0 -cagagaaggcaccaactgcc-3 0 primers (Brouwer et al. 2007 ). Cycling conditions were as follows: 1 cycle of 50 8C for 2 min, 95 8C for 10 min, 40 cycles of 95 8C for 15 s, and 60 8C for 1 min. Results were normalized to the HPRT1 gene (forward primer 5 0 -gctgaagatttggaaaaggtg-3 0 ; reverse primer 5 0 -aatccagcaggtcagcaaag-3 0 ) (Hvid et al. 2011) using the Pffafl mathematical model for relative quantification. Each cDNA sample was run in triplicate. RNA was obtained in three independent experiments for the three groups of rats, and each extract assayed at least two times.
Statistical analysis
Data are expressed as the meanGS.E.M. of three experiments. Representative gels of WB are shown in the figures. Statistical analysis was performed by ANOVA followed by the Bonferroni test or by Kruskal-Wallis followed by the Dunn test. Values of P!0.05 were considered significant.
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